256376-72-4 Usage
Indazole derivative
The compound belongs to the class of indazole derivatives, which are organic compounds that contain a five-membered ring with the formula C3H2N and various substituents.
Carbonitrile functional group
The compound contains a carbonitrile functional group (C≡N), which is a triple bond between a carbon atom and a nitrogen atom.
Pharmaceutical applications
The compound has potential pharmaceutical applications, particularly in the development of new drugs.
Medicinal chemistry and drug discovery
The structure and properties of the compound make it a promising candidate for research in the fields of medicinal chemistry and drug discovery.
Fluorophenylmethyl substituent
The presence of a fluorophenylmethyl substituent (a group with a fluorine atom attached to a phenyl ring) enhances the potential of the compound as a bioactive compound.
Interesting target for further study
The compound is an interesting target for further study in the pharmaceutical industry due to its potential as a bioactive compound.
Check Digit Verification of cas no
The CAS Registry Mumber 256376-72-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,6,3,7 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 256376-72:
(8*2)+(7*5)+(6*6)+(5*3)+(4*7)+(3*6)+(2*7)+(1*2)=164
164 % 10 = 4
So 256376-72-4 is a valid CAS Registry Number.
256376-72-4Relevant articles and documents
SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES.
-
Page/Page column 129; 130, (2013/04/24)
Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
Substituted pyrazole derivatives
-
Page column 34, (2010/02/09)
The present invention relates to novel substituted pyrazole derivatives of the general formula (I) in which the substituents R1, R2, R3, A, X and Y are each as defined, and to processes for their preparation and to their use as medicaments, in particular as medicaments for the treatment of cardiovascular disorders.
